Ratings Saudi Pharmaceutical Industries and Medical Appliances Corporation
Equities
2070
SA0007879188
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
37.3 SAR | +2.19% | -1.45% | -1.32% |
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
Weaknesses
- The company is in debt and has limited leeway for investment
- With an expected P/E ratio at 50.52 and 28.88 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company appears highly valued given the size of its balance sheet.
- The company is highly valued given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Pharmaceuticals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-1.32% | 1.2B | - | ||
+30.50% | 699B | C+ | ||
+25.07% | 571B | B | ||
-4.79% | 364B | C+ | ||
+18.02% | 326B | B- | ||
+2.73% | 286B | C+ | ||
+14.68% | 236B | B+ | ||
+4.71% | 198B | B- | ||
-12.43% | 194B | A+ | ||
-3.63% | 154B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 2070 Stock
- Ratings Saudi Pharmaceutical Industries and Medical Appliances Corporation